Busacca CA - Search Results

1

Synthesis of a potent cathepsin s inhibitor labeled with deuterium and carbon-14.

Latli B, Hrapchak M, Lorenz JC, Busacca CA, Senanayake C. Latli B, et al. Among authors: busacca ca. Curr Radiopharm. 2012 Oct;5(4):314-7. doi: 10.2174/1874471011205040314. Curr Radiopharm. 2012. PMID: 22724423

2

Large-scale asymmetric synthesis of a cathepsin S inhibitor.

Lorenz JC, Busacca CA, Feng X, Grinberg N, Haddad N, Johnson J, Kapadia S, Lee H, Saha A, Sarvestani M, Spinelli EM, Varsolona R, Wei X, Zeng X, Senanayake CH. Lorenz JC, et al. Among authors: busacca ca. J Org Chem. 2010 Feb 19;75(4):1155-61. doi: 10.1021/jo9022809. J Org Chem. 2010. PMID: 20102230

3

Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon-13 and carbon-14.

Latli B, Hrapchak M, Chevliakov M, Li G, Campbell S, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2015 May 30;58(6):250-60. doi: 10.1002/jlcr.3294. Epub 2015 May 11. J Labelled Comp Radiopharm. 2015. PMID: 25964148

4

A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.

Latli B, Hrapchak M, Gao JJ, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2015 Jul;58(9):390-4. doi: 10.1002/jlcr.3319. Epub 2015 Jul 20. J Labelled Comp Radiopharm. 2015. PMID: 26190342

5

A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium.

Latli B, Eriksson M, Hrapchak M, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2016 Jun 30;59(8):300-4. doi: 10.1002/jlcr.3398. Epub 2016 Apr 13. J Labelled Comp Radiopharm. 2016. PMID: 27073120

6

Carbon-13 and carbon-14 labeled dabigatran etexilate and tritium labeled dabigatran.

Latli B, Kiesling R, Aßfalg S, Chevliakov M, Hrapchak M, Campbell S, Gonnella N, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2016 Dec;59(14):648-656. doi: 10.1002/jlcr.3402. Epub 2016 May 5. J Labelled Comp Radiopharm. 2016. PMID: 27146196

7

Buscopan labeled with carbon-14 and deuterium.

Latli B, Stiasni M, Hrapchak M, Li Z, Grinberg N, Lee H, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2016 Nov;59(13):557-564. doi: 10.1002/jlcr.3463. Epub 2016 Oct 17. J Labelled Comp Radiopharm. 2016. PMID: 27753138

8

Potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 labeled with carbon-13 and carbon-14.

Latli B, Hrapchak M, Savoie J, Zhang Y, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2017 Jul;60(9):420-430. doi: 10.1002/jlcr.3518. Epub 2017 Jun 14. J Labelled Comp Radiopharm. 2017. PMID: 28494515

9

Potent and selective CC chemokine receptor 1 antagonists labeled with carbon-13, carbon-14, and tritium.

Latli B, Hrapchak M, Cheveliakov M, Reeves JT, Marsini M, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2018 May 15. doi: 10.1002/jlcr.3635. Online ahead of print. J Labelled Comp Radiopharm. 2018. PMID: 29766547

10

Synthesis of highly potent lymphocyte function-associated antigen-1 antagonists labeled with carbon-14 and with stable isotopes, part 3.

Latli B, Hrapchak M, Li G, Lorenz J, Horan J, Busacca CA, Senanayake CH. Latli B, et al. Among authors: busacca ca. J Labelled Comp Radiopharm. 2019 Feb;62(2):77-85. doi: 10.1002/jlcr.3698. Epub 2018 Dec 12. J Labelled Comp Radiopharm. 2019. PMID: 30466143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters